WESTLAKE VILLAGE, Calif., Sept. 15, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that Arcutis management will participate in a fireside chat presentation during the Cantor Fitzgerald Global Healthcare Conference 2020 taking place Sept. 15-17, 2020.
News Ticker
- [ September 28, 2023 ] TAE Life Sciences Celebrates Collaboration Milestones and Unveils Alphabeam for in-hospital BNCT at ASTRO 2023 Annual Meeting Los Angeles Biotech News
- [ September 28, 2023 ] Alfred Mann Foundation Rebrands as huMannity Medtec, Unveiling a Bold, Future-Focused Identity Los Angeles Biotech News
- [ September 28, 2023 ] Medical Laboratory Scientist – VIR Healthway – Santa Monica, CA Los Angeles Biotech Jobs
- [ September 28, 2023 ] New Neoadjuvant Trial Confirms the Predictive Utility of MammaPrint® + BluePrint® Los Angeles Biotech News
- [ September 28, 2023 ] Immunis Welcomes UC Berkeley Professor Irina Conboy to the Scientific Advisory Board Los Angeles Biotech News
Copyright © 2023 Biotech Networks, LLC
